To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy
- PMID: 24799991
- PMCID: PMC4009478
- DOI: 10.4254/wjh.v6.i4.226
To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy
Abstract
Hepatitis B virus (HBV) infection is a global public health problem, with an estimated 350 million people worldwide chronically infected and approximately 500000 who die annually from HBV-related liver diseases. Management of chronic HBV is challenging and waves of guidelines emerge every year. One of the hottest topics and a matter of debate is the management of patients in their early immunotolerant phase of infection. With the lack of evidence, dealing with this particular subset of patients creates a great conflict with opposing views. In this review, the author highlights the pros and cons of these views and proposes a reasonable solution to resolve this dilemma.
Keywords: Hepatitis B Virus; Immunotolerant phase; Liver biopsy; Nucleotide analogue; Polymerase chain reaction.
Similar articles
-
China's efforts to shed its title of "Leader in liver disease".Drug Discov Ther. 2007 Oct;1(2):84-5. Drug Discov Ther. 2007. PMID: 22504391
-
[New insights into immunotolerant phase of chronic hepatitis B virus infection].Zhonghua Gan Zang Bing Za Zhi. 2021 Mar 20;29(3):284-288. doi: 10.3760/cma.j.cn501113-20200629-00352. Zhonghua Gan Zang Bing Za Zhi. 2021. PMID: 33902199 Chinese.
-
HBV: Do I treat my immunotolerant patients?Liver Int. 2016 Jan;36 Suppl 1:93-9. doi: 10.1111/liv.12996. Liver Int. 2016. PMID: 26725904 Review.
-
Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.Pediatr Infect Dis J. 2003 Apr;22(4):345-9. doi: 10.1097/01.inf.0000059443.49414.8b. Pediatr Infect Dis J. 2003. PMID: 12690275 Clinical Trial.
-
Antiviral therapy for chronic hepatitis B: a review.Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):63-70. doi: 10.2174/1568010043483908. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15032642 Review.
References
-
- Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733–1745. - PubMed
-
- Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942–1956. - PubMed
-
- Daniels G. A century of human blood groups. Wien Klin Wochenschr. 2001;113:781–786. - PubMed
-
- Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med. 2004;350:1118–1129. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous